Fact Sheets

December 22, 2025 | Controlled Substances Act, Fact Sheets, Psychedelics, Substance Misuse

Psilocybin is a chemical compound produced by more than 100 species of mushrooms, many of which belong to the genus Psilocybe, found growing around the world. Various indigenous cultures have consumed psilocybin-containing mushrooms for medical purposes and as part of spiritual ceremonies for thousands of years. In 1970, Congress enacted the Controlled Substances Act and categorized psilocybin and other psychedelic substances as Schedule I controlled substances, which effectively stopped the research into the therapeutic effects of psilocybin for several decades. Today, psilocybin remains a Schedule I controlled substance at the federal level and it is also classified as a Schedule I controlled substance in 47 states and the District of Columbia. Despite the continued challenges of researching Schedule I controlled substances, the 21st century has brought forth a renewed interest in investigating the therapeutic potential of psilocybin....

December 16, 2025 | Criminal Justice, Data Collection, Fact Sheets, Law Enforcement, Public Safety

Automatic license plate recognition systems (ALPRs) are camera systems that capture license plate data of vehicles and are available in fixed, mobile, and portable applications. ALPR systems automatically capture images or videos of all vehicles that pass the camera if the system algorithm detects what it determines to be a license plate. A computer algorithm then converts the image or video into readable-data, that includes the license plate number and any additional information that the system is set up to detect. This data can then be used by law enforcement for a variety of investigative purposes....

August 28, 2025 | Controlled Substances, Criminal Justice, Fact Sheets, Harm Reduction, Medication Assisted Treatment (MAT), Opioids, Recovery, Substance Misuse, Treatments

Through the use of medications for addiction treatment (MAT), an individual’s substance use, withdrawal symptoms, and the physiological and psychological cravings can be controlled, enabling the person to begin treatment while in a correctional facility and be released as a person in, or on his or her way to, recovery. Research shows that that the use of MAT for Opioid Use Disorder in correctional settings is a cost-effective and life-saving intervention....

July 30, 2025 | Cannabidiol (CBD), Controlled Substances, Fact Sheets, Marijuana, Prescription Drugs, Substance Misuse, Synthetic Drugs

In this fact sheet, LAPPA examines the features of the Snapchat app that can facilitate online drug transactions, the theory and progression of a major lawsuit against Snap brought by parents of overdose victims, and other recent legal and legislative actions taken against Snap for its alleged role in online drug sales....

April 16, 2025 | Controlled Substances, Fact Sheets, Prescription Drugs, Public Safety, Substance Misuse

Drug diversion is defined as any criminal act or deviation that removes a prescription drug from its intended path from the manufacturer to the patient, and while the act of diversion can occur in a variety of settings and be committed by anyone, it is particularly likely to occur in healthcare settings by healthcare workers due to the ease in which they can access prescription drugs. Drug diversion in health care is a serious issue that can result in patient harm, financial loss to the healthcare entity, and civil and criminal litigation based on the perpetrator’s actions....

April 7, 2025 | Controlled Substances, Fact Sheets, Substance Misuse

In this fact sheet the Legislative Analysis and Public Policy Association details the effects of the substance ibogaine in humans, reviews its regulation on the state and federal level, and highlights research being conducted relative to renewed interest in the substance....

March 5, 2025 | Controlled Substances, Fact Sheets, Insurance, Recovery, Treatments

The Medicaid Health Home State Plan Option, authorized by the Affordable Care Act in 2011, gives states the ability to create health home programs that provide comprehensive care coordination for Medicaid beneficiaries. Health home programs are required to “integrate and coordinate all primary, acute, behavioral health and long term services and supports” to treat the patient across his or her lifespan. Health home services must include all six of the following components: comprehensive case management; care coordination; health promotion; comprehensive transitional care/follow-up; patient and family support; and referral to community and social support services. This fact sheet provides an overview of Medicaid health homes, which are designed to assist beneficiaries in obtaining care for chronic conditions, including substance use disorder....

March 5, 2025 | Controlled Substances, Fact Sheets, Fentanyl, Harm Reduction, Public Safety, Synthetic Drugs

In mid 2024, community-based drug checking programs discovered the industrial chemical bis (2,2,6,6-tetramethyl-4-piperidyl) sebacate (BTMPS) in the illicit opioid supply in Portland, Oregon and Philadelphia, Pennsylvania. The substance appears as a white powder, and on industrial chemical websites, it is often referred to by its brand name, Tinuvin® 770. Used, among other things, as a protective coating on plastics to provide protection against ultraviolet rays, BTMPS belongs to a class of molecules called hindered amine light stabilizers. It is not approved for use in humans or animals, and it is not a scheduled or regulated substance in the U.S. This fact sheet provides an overview of the sudden increase in the presence of BTMPS in the illicit drug supply and its rapid proliferation across the country, which has left drug policy experts and harm reduction specialists puzzled as to why it is in the supply and how it will affect the individuals consuming it....